This session brings together two real-world case studies to explore how organisations have managed the transition from clinical trial systems into post-trial access.

• Managing the transition from trial supply to post trial access without disrupting patient treatment
• Resetting site expectations around ordering, reporting, and documentation outside trial frameworks
• Addressing practical blockers in complex regions where PTA setup is slower, less defined, or inconsistently interpreted
• Deciding when post trial access can accommodate limited data collection and when patients must remain in extension studies instead